Notes: (1) This trend is based on year legislation was adopted. (2) “Special form” may be single-copy,
duplicate or triplicate.
Source: LEXIS, U.S. Drug Enforcement Administration
“Prescription Accountability Resource Guide” September 1998, and updated
information obtained from states.
By: Pain & Policy Studies Group, University
of Wisconsin/WHO Collaborating Center,
2002.